Is severe confluent mucositis precisely qualified dose-limiting for altered radiotherapy for H&N cancer?

被引:0
|
作者
Maciejewski, B. [1 ]
机构
[1] MSC Inst Branch GL, Ctr Canc, Gliwice, Poland
关键词
D O I
10.1016/j.ijrobp.2007.07.1631
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
2454
引用
收藏
页码:S454 / S454
页数:1
相关论文
共 50 条
  • [31] The importance of FDG-PET combined with CT for tumor delineation for radiotherapy for H&N cancer compared to CT only
    Terhaard, C. H. J.
    Glaudemans, A. G.
    Hobbelink, M. G. G.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2007, 69 (03): : S439 - S439
  • [32] Performance of an atlas-based auto-segmentation software for MRI-only H&N cancer radiotherapy
    Riga, S.
    Carsana, C.
    Felisi, M.
    Daniela, S.
    Domenico, L.
    Monti, A. F.
    Pellegrini, R. G.
    Curto, D.
    Gaia, M.
    Maigualca, O. E. Panchi
    Bortolato, B.
    Bracco, F.
    Vanzulli, A.
    Palazzi, M.
    Torresin, A.
    RADIOTHERAPY AND ONCOLOGY, 2022, 170 : S1466 - S1467
  • [33] The kinetics of γ-H2AX during radiotherapy of head and neck cancer potentially allow for prediction of severe mucositis
    Kazmierska, Joanna
    Barczak, Wojciech
    Winiecki, Tomasz
    Luczewski, Lukasz
    Marciniak, Magdalena
    Suchorska, Wiktoria
    RADIOLOGY AND ONCOLOGY, 2020, 54 (01) : 96 - 102
  • [34] Evaluation of the Lens-absorbed Dose of the Scattered Radiation Generated During Tomotherapy IMRT to the H&N Cancer Patient
    Choi, Jae-Won
    Lee, Hae-Kag
    Choi, Jae-Hwan
    Choi, Cheon Woong
    Ju, Myung Sik
    Chang, Sok Soon
    Park, Cheol-Soo
    JOURNAL OF MAGNETICS, 2017, 22 (01) : 141 - 145
  • [35] FDG-PET combined with CT considerably alters tumour delineation for radiotherapy for H&N cancer compared to CT only
    Terhaard, C.
    de Keizer, B.
    Hobbelink, M.
    RADIOTHERAPY AND ONCOLOGY, 2007, 82 : S6 - S6
  • [36] VMAT in Prostate and Head and Neck (H&N) Cancer: No Major Effect of Multileaf Collimator (MLC) Leaf Width on Dose Distribution
    Lafond, C.
    Jouyaux, F.
    Bellec, J.
    Toublanc, S.
    Cazoulat, G.
    Louvel, G.
    Le Prise, E.
    De Crevoisier, R.
    Chajon, E.
    Manens, J.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 78 (03): : S845 - S846
  • [37] Dose variation on the simultaneous irradiation of head and neck (H&N) cancer and supraclavicular nodal fields with step-and-shoot IMRT
    Cheng, C
    Chopra, K
    Das, I
    MEDICAL PHYSICS, 2005, 32 (06) : 1981 - 1981
  • [38] Bacterial meningitis observed in a phase I trial of vinorelbine, cisplatin and thoracic radiotherapy for non-small cell lung cancer: Report of a case and discussion on dose-limiting toxicity
    Sekine, I
    Matsuda, T
    Saisho, T
    Watanabe, H
    Yamamoto, N
    Kunitoh, H
    Ohe, Y
    Tamura, T
    Kodama, T
    Saijo, N
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2000, 30 (09) : 401 - 405
  • [39] Phase I study of concurrent UFT®/leucovorin (UTT/LV) and hyperfractionated radiotherapy (RT) in advanced head and neck (H&N) cancer.
    Mercke, C
    Björk-Eriksson, T
    Nyman, J
    CLINICAL CANCER RESEARCH, 2000, 6 : 4541S - 4541S
  • [40] Late toxicity in head and neck cancer (H&N) patients (pts) treated with hyperfractionated (HF) or accelerated (AC) radiotherapy (RT) and chemotherapy (CT).
    Roth, BM
    Giglio, R
    Cerchietti, L
    Saborio, AB
    Cuartero, V
    Menendez, P
    Pogany, C
    Mickiewicz, E
    Bonomi, MR
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 515S - 515S